136 related articles for article (PubMed ID: 9731051)
1. IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma.
Bowman L; Grossmann M; Rill D; Brown M; Zhong WY; Alexander B; Leimig T; Coustan-Smith E; Campana D; Jenkins J; Woods D; Kitchingman G; Vanin E; Brenner M
Blood; 1998 Sep; 92(6):1941-9. PubMed ID: 9731051
[TBL] [Abstract][Full Text] [Related]
2. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma.
Rousseau RF; Haight AE; Hirschmann-Jax C; Yvon ES; Rill DR; Mei Z; Smith SC; Inman S; Cooper K; Alcoser P; Grilley B; Gee A; Popek E; Davidoff A; Bowman LC; Brenner MK; Strother D
Blood; 2003 Mar; 101(5):1718-26. PubMed ID: 12406881
[TBL] [Abstract][Full Text] [Related]
3. High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors.
Leimig T; Brenner M; Ramsey J; Vanin E; Blaese M; Dilloo D
Hum Gene Ther; 1996 Jun; 7(10):1233-9. PubMed ID: 8793547
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma.
Bowman LC; Grossmann M; Rill D; Brown M; Zhong WY; Alexander B; Leimig T; Coustan-Smith E; Campana D; Jenkins J; Woods D; Brenner M
Hum Gene Ther; 1998 Jun; 9(9):1303-11. PubMed ID: 9650615
[TBL] [Abstract][Full Text] [Related]
5. Advanced neuroblastoma impairs dendritic cell function in adoptive immunotherapy.
Redlinger RE; Mailliard RB; Barksdale EM
J Pediatr Surg; 2003 Jun; 38(6):857-62. PubMed ID: 12778381
[TBL] [Abstract][Full Text] [Related]
6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
7. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
8. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
[TBL] [Abstract][Full Text] [Related]
9. Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma.
Balicki D; Reisfeld RA; Pertl U; Beutler E; Lode HN
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11500-4. PubMed ID: 11016973
[TBL] [Abstract][Full Text] [Related]
10. B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.
Katsanis E; Xu Z; Bausero MA; Dancisak BB; Gorden KB; Davis G; Gray GS; Orchard PJ; Blazar BR
Cancer Gene Ther; 1995 Mar; 2(1):39-46. PubMed ID: 7542553
[TBL] [Abstract][Full Text] [Related]
11. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
[TBL] [Abstract][Full Text] [Related]
12. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
[TBL] [Abstract][Full Text] [Related]
14. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.
Mulders P; Tso CL; Pang S; Kaboo R; McBride WH; Hinkel A; Gitlitz B; Dannull J; Figlin R; Belldegrun A
J Immunother; 1998 May; 21(3):170-80. PubMed ID: 9610908
[TBL] [Abstract][Full Text] [Related]
17. Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma.
Iinuma H; Okinaga K; Fukushima R; Inaba T; Iwasaki K; Okinaga A; Takahashi I; Kaneko M
J Immunol; 2006 Mar; 176(6):3461-9. PubMed ID: 16517714
[TBL] [Abstract][Full Text] [Related]
18. A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastoma.
Russell HV; Strother D; Mei Z; Rill D; Popek E; Biagi E; Yvon E; Brenner M; Rousseau R
J Immunother; 2008; 31(9):812-9. PubMed ID: 18833006
[TBL] [Abstract][Full Text] [Related]
19. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy. Neuroblastoma as a model.
Cheung NK
Pediatr Clin North Am; 1991 Apr; 38(2):425-41. PubMed ID: 2006085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
